Norwegian Product Control Act
Recall Directorate of Health's 2014 Recommendation
If Directorate of Health's knowledge-obviated, medically & ethically flawed 2014 Recommendation were a consumer product/service it would be subject to the Norwegian Product Control Act. Consequently, after it was proven Directorate of Health's 2014 Recommendation caused "health damage" and "unacceptable risk of effect" to consumers, the EU Rapid Alert System would have been employed to: 1) warn consumers and the distribution channels (i.e., pregnant woman, midwives, nurses, doctors, clinics, hospitals, government healthcare institutions, etc.) of the risk and damage to consumers' health, 2) initiate a nationwide recall of the medical protocols that constitute Directorate of Health's 2014 Recommendation due to "an unacceptable risk of a product causing health damage". And, this would be followed by appropriate investigations.
However, such was, and is, not the case. No alert nor warning has been issued to notify consumers and healthcare providers of the "health damage" and "unacceptable risk of effect" to consumers due to Directorate of Health's 2014 Recommendation with their exclusive implementation of NCFM eSnurra Group's "method" within a government-mandated protocol of evidence-obviated medicine; and, no recall has been initiated to stop the systemic, ongoing problem; an ongoing problem proven to cause increased medical risks, critical medical mistakes and grievous medical harms; grievous medical harms which include perinatal mortality, or, in more common language, grievous medical harms which include dead babies.
It is interesting to note that the people and institutions who should be issuing the alert and warnings to consumers and healthcare providers and initiating the recall of Directorate of Health's 2014 Recommendation are the very same people and institutions who caused the problem, Directorate of Health and NCFM eSnurra Group, all of whom are complicit in misconduct, manipulation and corruption in conscious disregard of the consequences. And, now, after a plethora of fact-based evidence has been consolidated and presented within LailasCase.com, there is still no alert nor warning and no recall of that which is proven to cause increased medical risks, critical medical mistakes and grievous medical harms among Norway's women and their fetuses/babies; grievous medical harms which include dead babies, unnecessary surgeries and missed fetal pathology. Interestingly and somewhat uniquely, both the crime and the cover-up are in progress, simultaneously, in Norway. Among those who know better or should know better are those who see the fraud and decide to remain silent and those who refuse to believe that they have been fooled by the fraud (i.e., the misconduct, manipulation and corruption).
Norwegian Product Control Act
§ 1. The purpose of the Act
This Act aims to:
Section 6. Provisional Prohibition.
...
Section § 6 a. Recall, etc., of products and consumer services.
The King may make a decision pursuant to this section if there is an unacceptable risk of a product causing health damage or environmental disruption as mentioned in section 1, first paragraph, or for consumer service causing unacceptable risk of health damage.
Decisions may be that orders are issued to those who produce, introduce, process, translate, use or otherwise treat products to take action, alone or in collaboration, to reduce the risk of the product, including:
0 Appended by Law of 15 June 1990 No. 33 , Amended by Law of 11 June 1993 No. 68 , 29 Apr. 2005, No. 23 (May 1, 2005, App. Nov. 29, 2005, No. 396 ).
(Source: Norwegian Product Control Act. Lov om kontroll med produkter og forbrukertjenester. https://lovdata.no/dokument/NL/lov/1976-06-11-79;
§ 6 b. Notification obligation
Producer, importer or distributor who knows or ought to know that the product has made available to the user constitutes an unacceptable risk of effect as mentioned in section 1 shall immediately inform the supervisory authorities about this.
In case of non-safe consumer products, information to the regulatory authorities should also contain information about the measures taken to prevent the product from causing an unacceptable risk to the consumer.
The King may provide further rules regarding the obligation to notify and when exemptions may be made.
The notification obligation pursuant to the first and second paragraphs applies correspondingly to those who own or manage activities that offer consumer services and who know or ought to know that this constitutes an unacceptable risk of health damage.
0 Appended by Law of 15 June 1990 No. 33 , Amended by Law of 11 June 1993 No. 68 , 29 Apr. 2005, No. 23 (May 1, 2005, App. Nov. 29, 2005, No. 396 ).
(Source: Norwegian Product Control Act. Lov om kontroll med produkter og forbrukertjenester. https://lovdata.no/dokument/NL/lov/1976-06-11-79; also see: https://www.regjeringen.no/en/dokumenter/product-control-act/id172150/)
Product Recall & EU Rapid Alert System
Product recall notification obligations in the Norwegian Product Control Act are based on DIRECTIVE 2001/95/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 3 December 2001 on general product safety. Relevant sections of the Product Control Act (i.e., purpose and product recall & notification obligations) are included in the excerpts above.
"The EU Rapid Alert System enables quick exchange of information between 31 European countries and the European Commission about dangerous non-food products posing a risk to health and safety of consumers. However, in addition to non-food products, the Rapid Alert System is also not used for pharmaceuticals and medical devices." (Source: Rapid Alert System) (Source: Official Journal of the European Communities, DIRECTIVE 2001/95/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 3 December 2001 on general product safety (Text with EEA relevance) ANNEX II: PROCEDURES FOR THE APPLICATION OF RAPEX AND GUIDELINES FOR NOTIFICATIONS . 15.1.2002, L 11/15)
If Directorate of Health's knowledge-obviated, medically & ethically flawed 2014 Recommendation were a consumer product/service it would be subject to the Norwegian Product Control Act. Consequently, after it was proven Directorate of Health's 2014 Recommendation caused "health damage" and "unacceptable risk of effect" to consumers, the EU Rapid Alert System would have been employed to: 1) warn consumers and the distribution channels (i.e., pregnant woman, midwives, nurses, doctors, clinics, hospitals, government healthcare institutions, etc.) of the risk and damage to consumers' health, 2) initiate a nationwide recall of the medical protocols that constitute Directorate of Health's 2014 Recommendation due to "an unacceptable risk of a product causing health damage". And, this would be followed by appropriate investigations.
However, such was, and is, not the case. No alert nor warning has been issued to notify consumers and healthcare providers of the "health damage" and "unacceptable risk of effect" to consumers due to Directorate of Health's 2014 Recommendation with their exclusive implementation of NCFM eSnurra Group's "method" within a government-mandated protocol of evidence-obviated medicine; and, no recall has been initiated to stop the systemic, ongoing problem; an ongoing problem proven to cause increased medical risks, critical medical mistakes and grievous medical harms; grievous medical harms which include perinatal mortality, or, in more common language, grievous medical harms which include dead babies.
It is interesting to note that the people and institutions who should be issuing the alert and warnings to consumers and healthcare providers and initiating the recall of Directorate of Health's 2014 Recommendation are the very same people and institutions who caused the problem, Directorate of Health and NCFM eSnurra Group, all of whom are complicit in misconduct, manipulation and corruption in conscious disregard of the consequences. And, now, after a plethora of fact-based evidence has been consolidated and presented within LailasCase.com, there is still no alert nor warning and no recall of that which is proven to cause increased medical risks, critical medical mistakes and grievous medical harms among Norway's women and their fetuses/babies; grievous medical harms which include dead babies, unnecessary surgeries and missed fetal pathology. Interestingly and somewhat uniquely, both the crime and the cover-up are in progress, simultaneously, in Norway. Among those who know better or should know better are those who see the fraud and decide to remain silent and those who refuse to believe that they have been fooled by the fraud (i.e., the misconduct, manipulation and corruption).
- "If you see fraud and don't shout fraud, you are a fraud." --Nassim Nicholas Taleb
- “It's easier to fool people than to convince them that they have been fooled.” --Mark Twain
- “If liberty means anything at all, it means the right to tell people what they do not want to hear.” --George Orwell
Norwegian Product Control Act
§ 1. The purpose of the Act
This Act aims to:
- a) prevent products and consumer services from causing health damage, including ensuring that consumer products and consumer services are safe,
- b) prevent products from causing environmental pollution, including in the form of disruption of ecosystems, pollution, waste, noise and the like,
- c) prevent environmental pollution by promoting efficient use of energy in products.
0 Amended by Law of 2 April 1993 No. 38 , June 11, 1993 No. 68 , June 25, 1999 No. 53 , 29 Apr, 2005 No. 23 (May 1, 2005, App. Nov. 29, 2005, No. 396 ).
Section 6. Provisional Prohibition.
...
Section § 6 a. Recall, etc., of products and consumer services.
The King may make a decision pursuant to this section if there is an unacceptable risk of a product causing health damage or environmental disruption as mentioned in section 1, first paragraph, or for consumer service causing unacceptable risk of health damage.
Decisions may be that orders are issued to those who produce, introduce, process, translate, use or otherwise treat products to take action, alone or in collaboration, to reduce the risk of the product, including:
- a) Disclose warning information to distributors or users of the product.
- b) Recall the product from users or distributors.
- c) Harmlessize the product.
- a) Publish warning information to users
- b) Correct the relationship to which the risk of injury is caused
0 Appended by Law of 15 June 1990 No. 33 , Amended by Law of 11 June 1993 No. 68 , 29 Apr. 2005, No. 23 (May 1, 2005, App. Nov. 29, 2005, No. 396 ).
(Source: Norwegian Product Control Act. Lov om kontroll med produkter og forbrukertjenester. https://lovdata.no/dokument/NL/lov/1976-06-11-79;
§ 6 b. Notification obligation
Producer, importer or distributor who knows or ought to know that the product has made available to the user constitutes an unacceptable risk of effect as mentioned in section 1 shall immediately inform the supervisory authorities about this.
In case of non-safe consumer products, information to the regulatory authorities should also contain information about the measures taken to prevent the product from causing an unacceptable risk to the consumer.
The King may provide further rules regarding the obligation to notify and when exemptions may be made.
The notification obligation pursuant to the first and second paragraphs applies correspondingly to those who own or manage activities that offer consumer services and who know or ought to know that this constitutes an unacceptable risk of health damage.
0 Appended by Law of 15 June 1990 No. 33 , Amended by Law of 11 June 1993 No. 68 , 29 Apr. 2005, No. 23 (May 1, 2005, App. Nov. 29, 2005, No. 396 ).
(Source: Norwegian Product Control Act. Lov om kontroll med produkter og forbrukertjenester. https://lovdata.no/dokument/NL/lov/1976-06-11-79; also see: https://www.regjeringen.no/en/dokumenter/product-control-act/id172150/)
Product Recall & EU Rapid Alert System
Product recall notification obligations in the Norwegian Product Control Act are based on DIRECTIVE 2001/95/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 3 December 2001 on general product safety. Relevant sections of the Product Control Act (i.e., purpose and product recall & notification obligations) are included in the excerpts above.
"The EU Rapid Alert System enables quick exchange of information between 31 European countries and the European Commission about dangerous non-food products posing a risk to health and safety of consumers. However, in addition to non-food products, the Rapid Alert System is also not used for pharmaceuticals and medical devices." (Source: Rapid Alert System) (Source: Official Journal of the European Communities, DIRECTIVE 2001/95/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 3 December 2001 on general product safety (Text with EEA relevance) ANNEX II: PROCEDURES FOR THE APPLICATION OF RAPEX AND GUIDELINES FOR NOTIFICATIONS . 15.1.2002, L 11/15)
Maureen, Download this file: Saint Paul of the Crosss Class 1970.